Results 91 to 100 of about 7,011 (197)

Influence of acitretin on PBEC viability and barrier properties.

open access: yes, 2014
(A) Cell viability and cytotoxicity was measured after treatment with different concentrations of acitretin. Maximum amount of LDH (lysis) was set to 100% for the cytotoxicity assay whereas the cell viability of untreated cells (control) was set to 100%.
Kristina Endres (532488)   +5 more
core   +1 more source

Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 627-631, June 2026.
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin   +4 more
wiley   +1 more source

Therapeutic Options for IgA Pemphigus in Patients Refractory to Dapsone

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 415-424, June 2026.
ABSTRACT IgA pemphigus is a rare autoimmune blistering disorder with limited therapeutic guidance available due to its rarity and complex presentation. This comprehensive analysis evaluates the therapeutic outcomes of 67 published patients, emphasising the significant role of dapsone as the first‐line treatment.
Lorenz Frasheri   +2 more
wiley   +1 more source

Inconsistent standard of care for tuberculosis screening and preventive therapy before initiating systemic psoriasis treatment

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 737-744, June 2026.
Summary Background and Objectives Preventive tuberculosis (TB) therapy before initiating MTX or IL‐17/IL‐23/IL‐12/23p40 inhibitors for latent tuberculosis infection (LTBI) is supported by indirect evidence of TB reactivations with TNF inhibitors. However, direct evidence for MTX or IL‐17/IL‐23/IL‐12/23p40 inhibitors is limited.
Christoph Zeyen   +4 more
wiley   +1 more source

Constant variation in structure and function of geometrical isomers of acitretin under natural light

open access: yes, 2002
22-27Acitretin, a beneficial retinoid, was shown to undergo constant structural interconversions among its geometrical isomers (all-trans-acitretin, 9-cis-acitretin, 13-cis-acitretin, 9, 13-di-cis-acitretin, etc.) by photoisomerization under natural ...
Suzuki, Takakazu   +3 more
core  

Frontal Fibrosing Alopecia and Its Association With Genital Lichen Planus and Lichen Sclerosus: A Systematic Review

open access: yes
International Journal of Dermatology, Volume 65, Issue 7, Page 1477-1479, July 2026.
Samantha Bestavros   +2 more
wiley   +1 more source

Acute Generalized Pustular Psoriasis Developed Resistance to Adalimumab Was Successfully Treated with Narrowband Ultraviolet B and Acitretin: A Case Report

open access: yesClinical, Cosmetic and Investigational Dermatology, 2022
Xianjie Yang,* Juan Wang,* Huan Wang, Minmin Kong, Qiquann Chen Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing, People’s Republic of China*These authors contributed equally to this workCorrespondence ...
Yang X, Wang J, Wang H, Kong M, Chen Q
doaj  

Impact of weight‐loss interventions on psoriasis severity: A systematic review and meta‐analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 980-993, June 2026.
Weight‐loss interventions were associated with clinically and statistically significant improvements in psoriasis severity (PASI and PASI 75) and quality of life (DLQI). These findings support the role of weight‐loss interventions as effective adjuncts to medical therapy and their integration into holistic psoriasis care.
Sarah Morrow   +6 more
wiley   +1 more source

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 963-979, June 2026.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault   +51 more
wiley   +1 more source

Evaluation of the efficacy of acitretin therapy for nail psoriasis.

open access: yes, 2009
OBJECTIVE: To evaluate the therapeutic efficacy of acitretin in patients with isolated nail psoriasis. DESIGN: Open study involving 36 patients with moderate to severe nail psoriasis treated with acitretin.
Cameli N.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy